Efficacy and Safety of Dapagliflozin and Dapagliflozin Plus Saxagliptin in Combination With Metformin in Type 2 Diabetes Patients Compared With Sulphonylurea

• Status: Completed
• Trial end date: 2017-03-13

Summary

This study is being carried out to see if dapagliflozin and dapagliflozin plus saxagliptin as an addition to metformin is effective and safe in treating patients with type 2 diabetes when compared to glimepiride (sulphonylurea) as an addition to metformin treatment.

• Phase: Phase 4

Details

• Lead Sponsor: AstraZeneca
• Treatments: Dapagliflozin; Glimepiride; Metformin; Saxagliptin